Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Brain : a Journal of Neurology|March 1, 2014
Episodic ataxia type 1: clinical characterization, quality of life and genotype-phenotype correlationTracey D Graves, Yoon-Hee Cha, Angelika F Hahn, et al.
Science Translational Medicine|March 4, 2021
Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individualsEmily K Sims, Brian N Bundy, Kenneth Stier, et al.
Gynecologic Oncology|July 26, 2005
Implications of second-look laparotomy in the context of optimally resected stage III ovarian cancer: a non-randomized comparison using an explanatory analysis: a Gynecologic Oncology Group studyBenjamin E Greer, Brian N Bundy, Robert F Ozols, et al.
Diabetes Technology & Therapeutics|August 25, 2020
Comparing Beta Cell Preservation Across Clinical Trials in Recent-Onset Type 1 DiabetesLaura M Jacobsen, Brian N Bundy, Madison N Greco, et al.
JAMA|October 4, 2012
Mexiletine for symptoms and signs of myotonia in nondystrophic myotonia: a randomized controlled trialJeffrey M Statland, Brian N Bundy, Yunxia Wang, et al.
Diabetes Care|April 15, 2024
Early Metabolic Endpoints Identify Persistent Treatment Efficacy in Recent-Onset Type 1 Diabetes Immunotherapy TrialsLaura M Jacobsen, David Cuthbertson, Brian N Bundy, et al.
Muscle & Nerve|September 19, 2012
A quantitative measure of handgrip myotonia in non-dystrophic myotoniaJeffrey M Statland, Brian N Bundy, Yunxia Wang, et al.
The Lancet. Diabetes & Endocrinology|July 2, 2021
Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trialStephen E Gitelman, Brian N Bundy, Ele Ferrannini, et al.
Diabetes Care|July 18, 2018
Low-Dose Anti-Thymocyte Globulin (ATG) Preserves β-Cell Function and Improves HbA<sub>1c</sub> in New-Onset Type 1 DiabetesMichael J Haller, Desmond A Schatz, Jay S Skyler, et al.
The New England Journal of Medicine|June 11, 2019
An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 DiabetesKevan C Herold, Brian N Bundy, S Alice Long, et al.
Pageof 4